Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry.
Selvarajah A, Tavenier AH, Bor WL, Houben V, Rasoul S, Kaplan E, Teeuwen K, Hofma SH, Lipsic E, Amoroso G, van Leeuwen MAH, Berg JMT, van 't Hof AWJ, Hermanides RS. Selvarajah A, et al. Among authors: amoroso g. BMC Cardiovasc Disord. 2021 Jun 12;21(1):292. doi: 10.1186/s12872-021-02093-4. BMC Cardiovasc Disord. 2021. PMID: 34118880 Free PMC article.
A randomized comparison of manual versus mechanical thrombus removal in primary percutaneous coronary intervention in the treatment of ST-segment elevation myocardial infarction (TREAT-MI).
Vink MA, Patterson MS, van Etten J, Ijsselmuiden AJ, Dirksen MT, Amoroso G, Slagboom T, Laarman G, Kiemeneij F. Vink MA, et al. Among authors: amoroso g. Catheter Cardiovasc Interv. 2011 Jul 1;78(1):14-9. doi: 10.1002/ccd.22932. Catheter Cardiovasc Interv. 2011. PMID: 21681888 Clinical Trial.
One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.
Koch KT, Grundeken MJ, Vos NS, IJsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G. Koch KT, et al. Among authors: amoroso g. EuroIntervention. 2015 Jul;11(3):264-71. doi: 10.4244/EIJY15M02_08. EuroIntervention. 2015. PMID: 25692610 Free article. Clinical Trial.
Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation.
Hollander MR, van Leeuwen MA, van der Heijden DJ, Keizer VM, van de Ven PM, IJsselmuiden SJ, Van Mieghem NM, Amoroso G, Ritt MJ, Knaapen P, van Royen N. Hollander MR, et al. Among authors: amoroso g. EuroIntervention. 2017 Feb 20;12(14):1773-1781. doi: 10.4244/EIJ-D-16-00337. EuroIntervention. 2017. PMID: 27725319 Free article.
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
Lu H, Grundeken MJ, Vos NS, IJsselmuiden AJJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JGP, Amoroso G, de Winter RJ, Koch KT. Lu H, et al. Among authors: amoroso g. EuroIntervention. 2017 Aug 4;13(5):e572-e577. doi: 10.4244/EIJ-D-16-00676. EuroIntervention. 2017. PMID: 28191875 Free article. Clinical Trial.
A clinical risk score to identify patients at high risk of very late stent thrombosis.
Godschalk TC, Gimbel ME, Nolet WW, van Kessel DJ, Amoroso G, Dewilde WJ, Wykrzykowska JJ, Janssen PW, Bergmeijer TO, Kelder JC, Heestermans T, Ten Berg JM. Godschalk TC, et al. Among authors: amoroso g. J Interv Cardiol. 2018 Apr;31(2):159-169. doi: 10.1111/joic.12494. Epub 2018 Feb 22. J Interv Cardiol. 2018. PMID: 29468725 Free article.
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.
Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ. Zivelonghi C, et al. Among authors: amoroso g. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2. Catheter Cardiovasc Interv. 2019. PMID: 30280464 Clinical Trial.
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Fagel ND, Amoroso G, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JP, Patterson MS, Oosterwerff EFJ, Vos NS, Verheugt FWA, Tijssen JGP, de Winter RJ, Riezebos RK. Fagel ND, et al. Among authors: amoroso g. Am Heart J. 2021 Apr;234:42-50. doi: 10.1016/j.ahj.2021.01.001. Epub 2021 Jan 7. Am Heart J. 2021. PMID: 33422517 Clinical Trial.
155 results